Filing Details
- Accession Number:
- 0001235802-20-000071
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-07-01 18:02:07
- Reporting Period:
- 2020-06-29
- Accepted Time:
- 2020-07-01 18:02:07
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1492658 | Wright Medical Group N.v. | WMGI | Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) | 980509600 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1621200 | Wesley Jonathan Porter | 1023 Cherry Road Memphis TN 38117 | Svp, Chief Compliance Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares, Par Value Eur 0.03 Per Share | Acquisiton | 2020-06-29 | 7,838 | $0.00 | 36,537 | No | 4 | A | Direct | |
Ordinary Shares, Par Value Eur 0.03 Per Share | Disposition | 2020-06-30 | 2,925 | $29.55 | 33,612 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | S | Direct |
Footnotes
- Represents the payout of a performance share unit award for the June 26, 2017 - June 28, 2020 performance period under the Wright Medical Group N.V. 2017 Equity and Incentive Plan, as approved by the Issuer's Compensation Committee of its Board of Directors. Performance share unit awards are paid in ordinary shares of the Issuer.
- Includes 5,173 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 4,259 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan.
- These shares were sold under a pre-arranged sales instruction pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, to cover the estimated tax withholding obligations in connection with the vesting of performance share unit awards.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.5501 to $29.555, inclusive. The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4.